Evidence map›Paper›PMID 33391457›Full record

ArticleTheranostics2021

IL-37 exerts therapeutic effects in experimental autoimmune encephalomyelitis through the receptor complex IL-1R5/IL-1R8.

Alba Sánchez-Fernández, Stephanie Zandee, Jesús Amo-Aparicio, Marc Charabati, Alexandre Prat, Cecilia Garlanda, Elan Z Eisenmesser, Charles A Dinarello, Rubèn López-Vales

Open access · goldAbstract read
In one paragraph

Article in Theranostics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. SIGIRR: An Orphan Receptor Mediating Anti-inflammatory Actions.Expert reviews in molecular medicine · 2025
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Alba Sánchez-FernándezInstitut de Neurociencies and Departament de Biologia Cel·lular, Fisiologia i Immunologia, Universitat Autonoma de Barcelona, Bellaterra, Catalonia, Spain.
Stephanie ZandeeDepartment of Neuroscience, Faculty of Medicine, Université de Montréal, and Neuroimmunology Unit, Centre de Recherche du CHUM (CRCHUM), Montréal, Québec, Canada.
Jesús Amo-AparicioInstitut de Neurociencies and Departament de Biologia Cel·lular, Fisiologia i Immunologia, Universitat Autonoma de Barcelona, Bellaterra, Catalonia, Spain.
Marc CharabatiDepartment of Neuroscience, Faculty of Medicine, Université de Montréal, and Neuroimmunology Unit, Centre de Recherche du CHUM (CRCHUM), Montréal, Québec, Canada.
Alexandre PratDepartment of Neuroscience, Faculty of Medicine, Université de Montréal, and Neuroimmunology Unit, Centre de Recherche du CHUM (CRCHUM), Montréal, Québec, Canada.
Cecilia GarlandaHumanitas Clinical and Research Center, 20089 Rozzano, Italy.
Elan Z EisenmesserDepartment of Biochemistry and Molecular Genetics, University of Colorado Denver, Aurora, CO 80238, USA.
Charles A DinarelloDepartment of Medicine, University of Colorado Denver, Aurora, CO 80045, USA.
Rubèn López-ValesInstitut de Neurociencies and Departament de Biologia Cel·lular, Fisiologia i Immunologia, Universitat Autonoma de Barcelona, Bellaterra, Catalonia, Spain.
Biomedical Research Networking Center on Neurodegenerative Diseases · ESUniversity of Colorado Denver · USHumanitas University · IT

Funding

Yeast-based HTS Assay Technologies for ProteasesR01AI015614 · NIAID · UNIVERSITY OF COLORADO DENVER · PI DINARELLO, CHARLES ANTHONY · 1985 to 2025
$8.5M
Pathogenesis of Fever in ManR56AI015614 · NIAID · UNIVERSITY OF COLORADO DENVER · PI DINARELLO, CHARLES ANTHONY · 2016 to 2016
$311k
Identifying the missing link in inflammatory signalingR56CA230069 · NCI · UNIVERSITY OF COLORADO DENVER · PI EISENMESSER, ELAN Z · 2019 to 2019
$233k
Interleukin-37: The molecular basis of the atypical interleukin-1 family dimerR03CA219743 · NCI · UNIVERSITY OF COLORADO DENVER · PI EISENMESSER, ELAN Z · 2017 to 2018
$156k
NCI NIH HHS R03 CA219743NCI NIH HHS R56 CA230069NIAID NIH HHS R01 AI015614NIAID NIH HHS R56 AI015614
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedAnimalsBrainEncephalomyelitis, Autoimmune, ExperimentalFemaleHumansInflammationInterleukin-1MaleMiceMice, KnockoutMice, TransgenicMiddle AgedMultiple Sclerosis, Chronic ProgressiveMultiple Sclerosis, Relapsing-RemittingIL37 protein, humanInterleukin-1Receptors, Interleukin-1SIGIRR protein, mousecytokinesexperimental autoimmune encephalomyelitisIL-1R8IL-37multiple sclerosis

Identifiers

PMID33391457
PMCPMC7681099
OpenAlexW3092306676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.